MDxHealth SA reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 19.4 million compared to USD 12.89 million a year ago. Net loss was USD 10.72 million compared to USD 12.44 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.76 a year ago.
For the full year, sales was USD 70.19 million compared to USD 37.05 million a year ago. Net loss was USD 43.1 million compared to USD 44.04 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to USD 2.78 a year ago.